FDA Warning Letter — Johnson & Johnson Pharmaceutical Research & Development, LLC

Case 64044 — FEI 3006192174

The FDA took a Warning Letter action against Johnson & Johnson Pharmaceutical Research & Development, LLC on Aug 10, 2009 (Raritan, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Johnson & Johnson Pharmaceutical Research & Development, LLC
Date
Aug 10, 2009
Fiscal Year
2009
Product Type
Drugs
Center
CDER
Location
Raritan, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.